Pediatric Astrocytoma Differential Diagnoses

1. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016 Jun. 131 (6):803-20. [QxMD MEDLINE Link].

2. Hales RK, Shokek O, Burger PC, Paynter NP, Chaichana KL, Quiñones-Hinojosa A, et al. Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis. J Neurooncol. 2010 Aug. 99(1):65-71. [QxMD MEDLINE Link].

3. Tihan T, Ersen A, Qaddoumi I, Sughayer MA, Tolunay S, Al-Hussaini M, et al. Pathologic characteristics of pediatric intracranial pilocytic astrocytomas and their impact on outcome in 3 countries: a multi-institutional study. Am J Surg Pathol. 2012 Jan. 36(1):43-55. [QxMD MEDLINE Link].

4. Lin A, Rodriguez FJ, Karajannis MA, Williams SC, Legault G, Zagzag D, et al. BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. J Neuropathol Exp Neurol. 2012 Jan. 71 (1):66-72. [QxMD MEDLINE Link].

5. Bar EE, Lin A, Tihan T, Burger PC, Eberhart CG. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol. 2008 Sep. 67 (9):878-87. [QxMD MEDLINE Link].

6. Marcotte EL, Domingues AM, Sample JM, Richardson MR, Spector LG. Racial and ethnic disparities in pediatric cancer incidence among children and young adults in the United States by single year of age. Cancer. 2021 Oct 1. 127 (19):3651-63. [QxMD MEDLINE Link].

7. Ait Khelifa-Gallois N, Laroussinie F, Puget S, Sainte-Rose C, Dellatolas G. Long-term functional outcome of patients with cerebellar pilocytic astrocytoma surgically treated in childhood. Brain Inj. 2014 Nov 10. 1-8. [QxMD MEDLINE Link].

8. Leroy HA, Baroncini M, Delestret I, Florent V, Vinchon M. Anorexia: an early sign of fourth ventricle astrocytoma in children. Childs Nerv Syst. 2014 Dec. 30(12):2089-95. [QxMD MEDLINE Link].

9. Belirgen M, Berrak SG, Ozdag H, Bozkurt SU, Eksioglu-Demiralp E, Ozek MM. Biologic tumor behavior in pilocytic astrocytomas. Childs Nerv Syst. 2012 Mar. 28(3):375-89. [QxMD MEDLINE Link].

10. Porkholm M, Raunio A, Vainionpää R, Salonen T, Hernesniemi J, Valanne L, et al. Molecular alterations in pediatric brainstem gliomas. Pediatr Blood Cancer. 2017 Aug 9. [QxMD MEDLINE Link].

11. Ardon H, Verbinnen B, Maes W, Beez T, Van Gool S, De Vleeschouwer S. Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination. J Immunol Methods. 2010 Jan 31. 352 (1-2):169-73. [QxMD MEDLINE Link].

12. Wagner LM, Adams VR. Targeting the PD-1 pathway in pediatric solid tumors and brain tumors. Onco Targets Ther. 2017. 10:2097-2106. [QxMD MEDLINE Link].

13. Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg. 1997 May. 86 (5):747-54. [QxMD MEDLINE Link].

14. [Guideline] HeadSmart brain tumours in children guidance. Guidelines. Available at https://www.guidelines.co.uk/cancer/headsmart-brain-tumours-in-children-guidance/454021.article. 2018 Apr 09; Accessed: September 21, 2021.

15. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol. 2005 Oct 20. 23(30):7621-31. [QxMD MEDLINE Link].

16. Pollack IF, Hamilton RL, Sobol RW, et al. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort. J Clin Oncol. 2006 Jul 20. 24(21):3431-7. [QxMD MEDLINE Link].

17. Akyüz C, Demir HA, Varan A, Yalçin B, Kutluk T, Büyükpamukçu M. Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center. Childs Nerv Syst. 2012 Jan. 28(1):111-5. [QxMD MEDLINE Link].

18. Chen L, Du C, Wang L, et al. Human positive coactivator 4 (PC4) is involved in the progression and prognosis of astrocytoma. J Neurol Sci. 2014 Nov 15. 346 (1-2):293-8. [QxMD MEDLINE Link].

19. Fernandez C, Figarella-Branger D, Girard N, et al. Pilocytic astrocytomas in children: prognostic factors--a retrospective study of 80 cases. Neurosurgery. 2003 Sep. 53(3):544-53; discussion 554-5. [QxMD MEDLINE Link].

20. Gilbertson RJ, Hill DA, Hernan R, et al. ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res. 2003 Sep 1. 9(10 Pt 1):3620-4. [QxMD MEDLINE Link].

21. Gururangan S, Fisher MJ, Allen JC, Herndon JE 2nd, Quinn JA, Reardon DA, et al. Temozolomide in children with progressive low-grade glioma. Neuro Oncol. 2007 Apr. 9(2):161-8. [QxMD MEDLINE Link].

22. Guthrie BL, Laws ER Jr. Supratentorial low-grade gliomas. Neurosurg Clin N Am. 1990 Jan. 1(1):37-48. [QxMD MEDLINE Link].

23. Huncharek M, Wheeler L, McGarry R, Geschwind JF. Chemotherapy response rates in recurrent/progressive pediatric glioma; results of a systematic review. ALYSIS. 1999 Jul-Aug. 19(4C):3569-74. [QxMD MEDLINE Link].

24. Jacobson DM. Gliomas of the anterior visual pathways. Neurosurg Clin N Am. 1999 Oct. 10(4):683-98, ix. [QxMD MEDLINE Link].

25. Khatua S, Peterson KM, Brown KM, et al. Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res. 2003 Apr 15. 63(8):1865-70. [QxMD MEDLINE Link].

26. Khaw SL, Coleman LT, Downie PA, Heath JA, Ashley DM. Temozolomide in pediatric low-grade glioma. Pediatr Blood Cancer. 2007 Nov. 49(6):808-11. [QxMD MEDLINE Link].

27. Komotar RJ, Mocco J, Carson BS, et al. Pilomyxoid astrocytoma: a review. MedGenMed. 2004. 6(4):42. [QxMD MEDLINE Link].

28. Kuo DJ, Weiner HL, Wisoff J, et al. Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas. J Pediatr Hematol Oncol. 2003 May. 25(5):372-8. [QxMD MEDLINE Link].

29. Lafay-Cousin L, Holm S, Qaddoumi I, et al. Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction. Cancer. 2005 Jun 15. 103(12):2636-42. [QxMD MEDLINE Link].

30. MacDonald TJ, Arenson EB, Ater J, et al. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933. Cancer. 2005 Dec 15. 104(12):2862-71. [QxMD MEDLINE Link].

31. Pollack IF, Finkelstein SD, Woods J, et al. Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med. 2002 Feb 7. 346(6):420-7. [QxMD MEDLINE Link].

32. Sharif S, Ferner R, Birch JM, et al. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol. 2006 Jun 1. 24(16):2570-5. [QxMD MEDLINE Link].

33. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10. 352(10):987-96. [QxMD MEDLINE Link].

34. Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, et al. Outcome for children Pediatr Blood Cancer</i>. 2007 Mar. 48 (3):278-84. [QxMD MEDLINE Link].

35. Vredenburgh JJ, Desjardins A, Herndon JE 2nd, et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol. 2007 Oct 20. 25(30):4722-9. [QxMD MEDLINE Link].

36. Bar EE, Lin A, Tihan T et al. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol. 2008. 67:878-887.

37. Mikaela Porkholm, Anna Raunio, Reetta Vainionpää, Tarja Salonen, Juha Hernesniemi, Leena Valanne, et al. Molecular alterations in pediatric brainstem gliomas. Pediatric Blood and Cancer. August 2017. [Full Text].

38. Hilko Ardon MD, Steven De Vleeschouwer MD, PhD, Frank Van Calenbergh MD, Laurence Claes PhD, Christof M. Kramm MD, et al. Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours. Pediatric Blood and Cancer. October 2009. [Full Text].

39. Lars M Wagner and Val R Adams. Targeting the PD-1 pathway in pediatric solid tumors and brain tumors. Onco Targets Ther. April 2017. [Full Text].

Lauren R Weintraub, MD Assistant Professor of Pediatrics, Division of Pediatric Hematology/Oncology, Albany Medical College; Co-Director, Pediatric Brain Tumor and Neurofibromatosis Program, Division of Pediatric Hematology/Oncology, Children's Hospital at Albany Medical Center

Lauren R Weintraub, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Clinical Oncology, American Society of Pediatric Hematology/Oncology

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Timothy P Cripe, MD, PhD, FAAP Chief, Division of Hematology/Oncology/BMT, Gordon Teter Endowed Chair in Pediatric Cancer, Nationwide Children's Hospital; Professor of Pediatrics, Ohio State University College of Medicine

Timothy P Cripe, MD, PhD, FAAP is a member of the following medical societies: American Academy of Pediatrics, American Association for the Advancement of Science, American Association for Cancer Research, American Pediatric Society, American Society of Gene and Cell Therapy, American Society of Pediatric Hematology/Oncology, Connective Tissue Oncology Society, Society for Pediatric Research, Children's Oncology Group

Disclosure: Nothing to disclose.

Max J Coppes, MD, PhD, MBA Executive Vice President, Chief Medical and Academic Officer, Renown Heath

Max J Coppes, MD, PhD, MBA is a member of the following medical societies: American College of Healthcare Executives, American Society of Pediatric Hematology/Oncology, Society for Pediatric Research

Disclosure: Nothing to disclose.

Tobey J MacDonald, MD Professor, Department of Pediatrics, Emory University School of Medicine; Director, Pediatric Brain Tumor Program, Aflac Chair for Neuro-Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta

Tobey J MacDonald, MD is a member of the following medical societies: American Association for Cancer Research, Society for Neuro-Oncology, International Society of Paediatric Oncology

Disclosure: Nothing to disclose.

Roger J Packer, MD Senior Vice President, Neuroscience and Behavioral Medicine, Director, Brain Tumor Institute, Children’s National Medical Center; Professor of Neurology and Pediatrics, The George Washington University School of Medicine and Health Sciences

Roger J Packer, MD is a member of the following medical societies: American Academy of Neurology, American Neurological Association, American Pediatric Society, Child Neurology Society, Children's Oncology Group, Society for Neuro-Oncology, Pediatric Brain Tumor Consortium, Neurofibromatosis Clinical Trials Consortium

Disclosure: Nothing to disclose.

Samuel Gross, MD Professor Emeritus, Department of Pediatrics, University of Florida College of Medicine; Clinical Professor, Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine; Adjunct Professor, Department of Pediatrics, Duke University School of Medicine

Samuel Gross, MD is a member of the following medical societies: American Association for Cancer Research, American Society for Blood and Marrow Transplantation, American Society of Clinical Oncology, American Society of Hematology, and Society for Pediatric Research

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article